You are here

Pandemics

Johnson & Johnson’s Coronavirus Vaccine Protects Monkeys, Study Finds

An experimental coronavirus vaccine developed by Johnson & Johnson protected monkeys from infection in a new study. It is the second vaccine candidate to show promising results in monkeys this week.

The company recently began a clinical trial in Europe and the United States to test its vaccine in people. It is one of more than 30 human trials for coronavirus vaccines underway across the world. But until these trials are complete — which will probably take several months — the monkey data offers the best clues to whether the vaccines will work.

Problem, Solution, SitRep, or ?: 

U.K. to start distributing 90 minute coronavirus and flu tests.

New 90-minute tests that can detect coronavirus and flu will be rolled out in hospitals and care homes from next week.

The "on-the-spot" swab and DNA tests will help distinguish between Covid-19 and other seasonal illnesses, the government said.

The health secretary said this would be "hugely beneficial" over the winter.

Currently, a third of tests take longer than 24 hours to process.

Problem, Solution, SitRep, or ?: 

Scientists Worry About Political Influence Over Coronavirus Vaccine Project

 

In April, with hospitals overwhelmed and much of the United States in lockdown, the Department of Health and Human Services produced a presentation for the White House arguing that rapid development of a coronavirus vaccine was the best hope to control the pandemic.

“DEADLINE: Enable broad access to the public by October 2020,” the first slide read, with the date in bold.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Pandemics
howdy folks